- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Bimatoprost (CAS 155206-00-1), also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertension and glaucoma. Bimatoprost is also used to treat eyelash hypotrichosis, or sparse eyelash growth. It was initially approved by the FDA in 2001 for ocular hypertension and later approved for hypothrichosis in 2008, as eyelash growth became a desirable adverse effect for patients using this drug.
According to our latest study, the global Latisse (Bimatoprost) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Latisse (Bimatoprost) (CAS 155206-00-1) key players include Chirogate International, Cayman Pharma, Zhejiang Ausun, Everlight Chemical, and Lianmin Biochemical etc. Global top three players hold a share about 40%. North America is the largest market, with a share about 90%.
This report is a detailed and comprehensive analysis for global Latisse (Bimatoprost) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Purity and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Latisse (Bimatoprost) market size and forecasts, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2018-2029
Global Latisse (Bimatoprost) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2018-2029
Global Latisse (Bimatoprost) market size and forecasts, by Purity and by Application, in consumption value ($ Million), sales quantity (g), and average selling prices (US$/g), 2018-2029
Global Latisse (Bimatoprost) market shares of main players, shipments in revenue ($ Million), sales quantity (g), and ASP (US$/g), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Latisse (Bimatoprost)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Latisse (Bimatoprost) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cayman Pharma, Tecoland Corporation, TCS Group, Changzhou BOHIV and Zhejiang Ausun, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Latisse (Bimatoprost) market is split by Purity and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Purity, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Purity
Below 99.5%
Other
Market segment by Application
Patented Product
General Products
Major players covered
Cayman Pharma
Tecoland Corporation
TCS Group
Changzhou BOHIV
Zhejiang Ausun
Ansion Pharma
Lianmin Biochemical
Chirogate International
Everlight Chemical
GENTEC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Latisse (Bimatoprost) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Latisse (Bimatoprost), with price, sales, revenue and global market share of Latisse (Bimatoprost) from 2018 to 2023.
Chapter 3, the Latisse (Bimatoprost) competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Latisse (Bimatoprost) breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Purity and application, with sales market share and growth rate by purity, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Latisse (Bimatoprost) market forecast, by regions, purity and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Latisse (Bimatoprost).
Chapter 14 and 15, to describe Latisse (Bimatoprost) sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Latisse (Bimatoprost)
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Purity
1.3.1 Overview: Global Latisse (Bimatoprost) Consumption Value by Purity: 2018 Versus 2022 Versus 2029
1.3.2 Below 99.5%
1.3.3 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Latisse (Bimatoprost) Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Patented Product
1.4.3 General Products
1.5 Global Latisse (Bimatoprost) Market Size & Forecast
1.5.1 Global Latisse (Bimatoprost) Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Latisse (Bimatoprost) Sales Quantity (2018-2029)
1.5.3 Global Latisse (Bimatoprost) Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Cayman Pharma
2.1.1 Cayman Pharma Details
2.1.2 Cayman Pharma Major Business
2.1.3 Cayman Pharma Latisse (Bimatoprost) Product and Services
2.1.4 Cayman Pharma Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Cayman Pharma Recent Developments/Updates
2.2 Tecoland Corporation
2.2.1 Tecoland Corporation Details
2.2.2 Tecoland Corporation Major Business
2.2.3 Tecoland Corporation Latisse (Bimatoprost) Product and Services
2.2.4 Tecoland Corporation Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Tecoland Corporation Recent Developments/Updates
2.3 TCS Group
2.3.1 TCS Group Details
2.3.2 TCS Group Major Business
2.3.3 TCS Group Latisse (Bimatoprost) Product and Services
2.3.4 TCS Group Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 TCS Group Recent Developments/Updates
2.4 Changzhou BOHIV
2.4.1 Changzhou BOHIV Details
2.4.2 Changzhou BOHIV Major Business
2.4.3 Changzhou BOHIV Latisse (Bimatoprost) Product and Services
2.4.4 Changzhou BOHIV Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Changzhou BOHIV Recent Developments/Updates
2.5 Zhejiang Ausun
2.5.1 Zhejiang Ausun Details
2.5.2 Zhejiang Ausun Major Business
2.5.3 Zhejiang Ausun Latisse (Bimatoprost) Product and Services
2.5.4 Zhejiang Ausun Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Zhejiang Ausun Recent Developments/Updates
2.6 Ansion Pharma
2.6.1 Ansion Pharma Details
2.6.2 Ansion Pharma Major Business
2.6.3 Ansion Pharma Latisse (Bimatoprost) Product and Services
2.6.4 Ansion Pharma Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Ansion Pharma Recent Developments/Updates
2.7 Lianmin Biochemical
2.7.1 Lianmin Biochemical Details
2.7.2 Lianmin Biochemical Major Business
2.7.3 Lianmin Biochemical Latisse (Bimatoprost) Product and Services
2.7.4 Lianmin Biochemical Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lianmin Biochemical Recent Developments/Updates
2.8 Chirogate International
2.8.1 Chirogate International Details
2.8.2 Chirogate International Major Business
2.8.3 Chirogate International Latisse (Bimatoprost) Product and Services
2.8.4 Chirogate International Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Chirogate International Recent Developments/Updates
2.9 Everlight Chemical
2.9.1 Everlight Chemical Details
2.9.2 Everlight Chemical Major Business
2.9.3 Everlight Chemical Latisse (Bimatoprost) Product and Services
2.9.4 Everlight Chemical Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Everlight Chemical Recent Developments/Updates
2.10 GENTEC
2.10.1 GENTEC Details
2.10.2 GENTEC Major Business
2.10.3 GENTEC Latisse (Bimatoprost) Product and Services
2.10.4 GENTEC Latisse (Bimatoprost) Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GENTEC Recent Developments/Updates
3 Competitive Environment: Latisse (Bimatoprost) by Manufacturer
3.1 Global Latisse (Bimatoprost) Sales Quantity by Manufacturer (2018-2023)
3.2 Global Latisse (Bimatoprost) Revenue by Manufacturer (2018-2023)
3.3 Global Latisse (Bimatoprost) Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Latisse (Bimatoprost) by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Latisse (Bimatoprost) Manufacturer Market Share in 2022
3.4.2 Top 6 Latisse (Bimatoprost) Manufacturer Market Share in 2022
3.5 Latisse (Bimatoprost) Market: Overall Company Footprint Analysis
3.5.1 Latisse (Bimatoprost) Market: Region Footprint
3.5.2 Latisse (Bimatoprost) Market: Company Product Type Footprint
3.5.3 Latisse (Bimatoprost) Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Latisse (Bimatoprost) Market Size by Region
4.1.1 Global Latisse (Bimatoprost) Sales Quantity by Region (2018-2029)
4.1.2 Global Latisse (Bimatoprost) Consumption Value by Region (2018-2029)
4.1.3 Global Latisse (Bimatoprost) Average Price by Region (2018-2029)
4.2 North America Latisse (Bimatoprost) Consumption Value (2018-2029)
4.3 Europe Latisse (Bimatoprost) Consumption Value (2018-2029)
4.4 Asia-Pacific Latisse (Bimatoprost) Consumption Value (2018-2029)
4.5 South America Latisse (Bimatoprost) Consumption Value (2018-2029)
4.6 Middle East and Africa Latisse (Bimatoprost) Consumption Value (2018-2029)
5 Market Segment by Purity
5.1 Global Latisse (Bimatoprost) Sales Quantity by Purity (2018-2029)
5.2 Global Latisse (Bimatoprost) Consumption Value by Purity (2018-2029)
5.3 Global Latisse (Bimatoprost) Average Price by Purity (2018-2029)
6 Market Segment by Application
6.1 Global Latisse (Bimatoprost) Sales Quantity by Application (2018-2029)
6.2 Global Latisse (Bimatoprost) Consumption Value by Application (2018-2029)
6.3 Global Latisse (Bimatoprost) Average Price by Application (2018-2029)
7 North America
7.1 North America Latisse (Bimatoprost) Sales Quantity by Purity (2018-2029)
7.2 North America Latisse (Bimatoprost) Sales Quantity by Application (2018-2029)
7.3 North America Latisse (Bimatoprost) Market Size by Country
7.3.1 North America Latisse (Bimatoprost) Sales Quantity by Country (2018-2029)
7.3.2 North America Latisse (Bimatoprost) Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Latisse (Bimatoprost) Sales Quantity by Purity (2018-2029)
8.2 Europe Latisse (Bimatoprost) Sales Quantity by Application (2018-2029)
8.3 Europe Latisse (Bimatoprost) Market Size by Country
8.3.1 Europe Latisse (Bimatoprost) Sales Quantity by Country (2018-2029)
8.3.2 Europe Latisse (Bimatoprost) Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Purity (2018-2029)
9.2 Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Latisse (Bimatoprost) Market Size by Region
9.3.1 Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Latisse (Bimatoprost) Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Latisse (Bimatoprost) Sales Quantity by Purity (2018-2029)
10.2 South America Latisse (Bimatoprost) Sales Quantity by Application (2018-2029)
10.3 South America Latisse (Bimatoprost) Market Size by Country
10.3.1 South America Latisse (Bimatoprost) Sales Quantity by Country (2018-2029)
10.3.2 South America Latisse (Bimatoprost) Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Purity (2018-2029)
11.2 Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Latisse (Bimatoprost) Market Size by Country
11.3.1 Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Latisse (Bimatoprost) Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Latisse (Bimatoprost) Market Drivers
12.2 Latisse (Bimatoprost) Market Restraints
12.3 Latisse (Bimatoprost) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Latisse (Bimatoprost) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Latisse (Bimatoprost)
13.3 Latisse (Bimatoprost) Production Process
13.4 Latisse (Bimatoprost) Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Latisse (Bimatoprost) Typical Distributors
14.3 Latisse (Bimatoprost) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Latisse (Bimatoprost) Consumption Value by Purity, (USD Million), 2018 & 2022 & 2029
Table 2. Global Latisse (Bimatoprost) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Cayman Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Cayman Pharma Major Business
Table 5. Cayman Pharma Latisse (Bimatoprost) Product and Services
Table 6. Cayman Pharma Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Cayman Pharma Recent Developments/Updates
Table 8. Tecoland Corporation Basic Information, Manufacturing Base and Competitors
Table 9. Tecoland Corporation Major Business
Table 10. Tecoland Corporation Latisse (Bimatoprost) Product and Services
Table 11. Tecoland Corporation Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Tecoland Corporation Recent Developments/Updates
Table 13. TCS Group Basic Information, Manufacturing Base and Competitors
Table 14. TCS Group Major Business
Table 15. TCS Group Latisse (Bimatoprost) Product and Services
Table 16. TCS Group Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. TCS Group Recent Developments/Updates
Table 18. Changzhou BOHIV Basic Information, Manufacturing Base and Competitors
Table 19. Changzhou BOHIV Major Business
Table 20. Changzhou BOHIV Latisse (Bimatoprost) Product and Services
Table 21. Changzhou BOHIV Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Changzhou BOHIV Recent Developments/Updates
Table 23. Zhejiang Ausun Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Ausun Major Business
Table 25. Zhejiang Ausun Latisse (Bimatoprost) Product and Services
Table 26. Zhejiang Ausun Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Zhejiang Ausun Recent Developments/Updates
Table 28. Ansion Pharma Basic Information, Manufacturing Base and Competitors
Table 29. Ansion Pharma Major Business
Table 30. Ansion Pharma Latisse (Bimatoprost) Product and Services
Table 31. Ansion Pharma Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Ansion Pharma Recent Developments/Updates
Table 33. Lianmin Biochemical Basic Information, Manufacturing Base and Competitors
Table 34. Lianmin Biochemical Major Business
Table 35. Lianmin Biochemical Latisse (Bimatoprost) Product and Services
Table 36. Lianmin Biochemical Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lianmin Biochemical Recent Developments/Updates
Table 38. Chirogate International Basic Information, Manufacturing Base and Competitors
Table 39. Chirogate International Major Business
Table 40. Chirogate International Latisse (Bimatoprost) Product and Services
Table 41. Chirogate International Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Chirogate International Recent Developments/Updates
Table 43. Everlight Chemical Basic Information, Manufacturing Base and Competitors
Table 44. Everlight Chemical Major Business
Table 45. Everlight Chemical Latisse (Bimatoprost) Product and Services
Table 46. Everlight Chemical Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Everlight Chemical Recent Developments/Updates
Table 48. GENTEC Basic Information, Manufacturing Base and Competitors
Table 49. GENTEC Major Business
Table 50. GENTEC Latisse (Bimatoprost) Product and Services
Table 51. GENTEC Latisse (Bimatoprost) Sales Quantity (g), Average Price (US$/g), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. GENTEC Recent Developments/Updates
Table 53. Global Latisse (Bimatoprost) Sales Quantity by Manufacturer (2018-2023) & (g)
Table 54. Global Latisse (Bimatoprost) Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Latisse (Bimatoprost) Average Price by Manufacturer (2018-2023) & (US$/g)
Table 56. Market Position of Manufacturers in Latisse (Bimatoprost), (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Latisse (Bimatoprost) Production Site of Key Manufacturer
Table 58. Latisse (Bimatoprost) Market: Company Product Type Footprint
Table 59. Latisse (Bimatoprost) Market: Company Product Application Footprint
Table 60. Latisse (Bimatoprost) New Market Entrants and Barriers to Market Entry
Table 61. Latisse (Bimatoprost) Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Latisse (Bimatoprost) Sales Quantity by Region (2018-2023) & (g)
Table 63. Global Latisse (Bimatoprost) Sales Quantity by Region (2024-2029) & (g)
Table 64. Global Latisse (Bimatoprost) Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Latisse (Bimatoprost) Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Latisse (Bimatoprost) Average Price by Region (2018-2023) & (US$/g)
Table 67. Global Latisse (Bimatoprost) Average Price by Region (2024-2029) & (US$/g)
Table 68. Global Latisse (Bimatoprost) Sales Quantity by Purity (2018-2023) & (g)
Table 69. Global Latisse (Bimatoprost) Sales Quantity by Purity (2024-2029) & (g)
Table 70. Global Latisse (Bimatoprost) Consumption Value by Purity (2018-2023) & (USD Million)
Table 71. Global Latisse (Bimatoprost) Consumption Value by Purity (2024-2029) & (USD Million)
Table 72. Global Latisse (Bimatoprost) Average Price by Purity (2018-2023) & (US$/g)
Table 73. Global Latisse (Bimatoprost) Average Price by Purity (2024-2029) & (US$/g)
Table 74. Global Latisse (Bimatoprost) Sales Quantity by Application (2018-2023) & (g)
Table 75. Global Latisse (Bimatoprost) Sales Quantity by Application (2024-2029) & (g)
Table 76. Global Latisse (Bimatoprost) Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Latisse (Bimatoprost) Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Latisse (Bimatoprost) Average Price by Application (2018-2023) & (US$/g)
Table 79. Global Latisse (Bimatoprost) Average Price by Application (2024-2029) & (US$/g)
Table 80. North America Latisse (Bimatoprost) Sales Quantity by Purity (2018-2023) & (g)
Table 81. North America Latisse (Bimatoprost) Sales Quantity by Purity (2024-2029) & (g)
Table 82. North America Latisse (Bimatoprost) Sales Quantity by Application (2018-2023) & (g)
Table 83. North America Latisse (Bimatoprost) Sales Quantity by Application (2024-2029) & (g)
Table 84. North America Latisse (Bimatoprost) Sales Quantity by Country (2018-2023) & (g)
Table 85. North America Latisse (Bimatoprost) Sales Quantity by Country (2024-2029) & (g)
Table 86. North America Latisse (Bimatoprost) Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Latisse (Bimatoprost) Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Latisse (Bimatoprost) Sales Quantity by Purity (2018-2023) & (g)
Table 89. Europe Latisse (Bimatoprost) Sales Quantity by Purity (2024-2029) & (g)
Table 90. Europe Latisse (Bimatoprost) Sales Quantity by Application (2018-2023) & (g)
Table 91. Europe Latisse (Bimatoprost) Sales Quantity by Application (2024-2029) & (g)
Table 92. Europe Latisse (Bimatoprost) Sales Quantity by Country (2018-2023) & (g)
Table 93. Europe Latisse (Bimatoprost) Sales Quantity by Country (2024-2029) & (g)
Table 94. Europe Latisse (Bimatoprost) Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Latisse (Bimatoprost) Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Purity (2018-2023) & (g)
Table 97. Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Purity (2024-2029) & (g)
Table 98. Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Application (2018-2023) & (g)
Table 99. Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Application (2024-2029) & (g)
Table 100. Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Region (2018-2023) & (g)
Table 101. Asia-Pacific Latisse (Bimatoprost) Sales Quantity by Region (2024-2029) & (g)
Table 102. Asia-Pacific Latisse (Bimatoprost) Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Latisse (Bimatoprost) Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Latisse (Bimatoprost) Sales Quantity by Purity (2018-2023) & (g)
Table 105. South America Latisse (Bimatoprost) Sales Quantity by Purity (2024-2029) & (g)
Table 106. South America Latisse (Bimatoprost) Sales Quantity by Application (2018-2023) & (g)
Table 107. South America Latisse (Bimatoprost) Sales Quantity by Application (2024-2029) & (g)
Table 108. South America Latisse (Bimatoprost) Sales Quantity by Country (2018-2023) & (g)
Table 109. South America Latisse (Bimatoprost) Sales Quantity by Country (2024-2029) & (g)
Table 110. South America Latisse (Bimatoprost) Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Latisse (Bimatoprost) Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Purity (2018-2023) & (g)
Table 113. Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Purity (2024-2029) & (g)
Table 114. Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Application (2018-2023) & (g)
Table 115. Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Application (2024-2029) & (g)
Table 116. Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Region (2018-2023) & (g)
Table 117. Middle East & Africa Latisse (Bimatoprost) Sales Quantity by Region (2024-2029) & (g)
Table 118. Middle East & Africa Latisse (Bimatoprost) Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Latisse (Bimatoprost) Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Latisse (Bimatoprost) Raw Material
Table 121. Key Manufacturers of Latisse (Bimatoprost) Raw Materials
Table 122. Latisse (Bimatoprost) Typical Distributors
Table 123. Latisse (Bimatoprost) Typical Customers
List of Figures
Figure 1. Latisse (Bimatoprost) Picture
Figure 2. Global Latisse (Bimatoprost) Consumption Value by Purity, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Latisse (Bimatoprost) Consumption Value Market Share by Purity in 2022
Figure 4. Below 99.5% Examples
Figure 5. Other Examples
Figure 6. Global Latisse (Bimatoprost) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Latisse (Bimatoprost) Consumption Value Market Share by Application in 2022
Figure 8. Patented Product Examples
Figure 9. General Products Examples
Figure 10. Global Latisse (Bimatoprost) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Latisse (Bimatoprost) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Latisse (Bimatoprost) Sales Quantity (2018-2029) & (g)
Figure 13. Global Latisse (Bimatoprost) Average Price (2018-2029) & (US$/g)
Figure 14. Global Latisse (Bimatoprost) Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Latisse (Bimatoprost) Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Latisse (Bimatoprost) by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Latisse (Bimatoprost) Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Latisse (Bimatoprost) Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Latisse (Bimatoprost) Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Latisse (Bimatoprost) Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Latisse (Bimatoprost) Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Latisse (Bimatoprost) Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Latisse (Bimatoprost) Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Latisse (Bimatoprost) Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Latisse (Bimatoprost) Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Latisse (Bimatoprost) Sales Quantity Market Share by Purity (2018-2029)
Figure 27. Global Latisse (Bimatoprost) Consumption Value Market Share by Purity (2018-2029)
Figure 28. Global Latisse (Bimatoprost) Average Price by Purity (2018-2029) & (US$/g)
Figure 29. Global Latisse (Bimatoprost) Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Latisse (Bimatoprost) Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Latisse (Bimatoprost) Average Price by Application (2018-2029) & (US$/g)
Figure 32. North America Latisse (Bimatoprost) Sales Quantity Market Share by Purity (2018-2029)
Figure 33. North America Latisse (Bimatoprost) Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Latisse (Bimatoprost) Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Latisse (Bimatoprost) Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Latisse (Bimatoprost) Sales Quantity Market Share by Purity (2018-2029)
Figure 40. Europe Latisse (Bimatoprost) Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Latisse (Bimatoprost) Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Latisse (Bimatoprost) Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Latisse (Bimatoprost) Sales Quantity Market Share by Purity (2018-2029)
Figure 49. Asia-Pacific Latisse (Bimatoprost) Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Latisse (Bimatoprost) Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Latisse (Bimatoprost) Consumption Value Market Share by Region (2018-2029)
Figure 52. China Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Latisse (Bimatoprost) Sales Quantity Market Share by Purity (2018-2029)
Figure 59. South America Latisse (Bimatoprost) Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Latisse (Bimatoprost) Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Latisse (Bimatoprost) Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Latisse (Bimatoprost) Sales Quantity Market Share by Purity (2018-2029)
Figure 65. Middle East & Africa Latisse (Bimatoprost) Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Latisse (Bimatoprost) Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Latisse (Bimatoprost) Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Latisse (Bimatoprost) Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Latisse (Bimatoprost) Market Drivers
Figure 73. Latisse (Bimatoprost) Market Restraints
Figure 74. Latisse (Bimatoprost) Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Latisse (Bimatoprost) in 2022
Figure 77. Manufacturing Process Analysis of Latisse (Bimatoprost)
Figure 78. Latisse (Bimatoprost) Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
